Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2008
07/24/2008US20080176321 Immunoglobulin specific to antiapoptosis polypeptide for use in treatment and prevention of degenerative or hyperproliferative disorder
07/24/2008US20080176312 Using immunoaffinity chromatography to isolate blood coagulation factor; treatment of myeloproliferative and thrombotic disorders
07/24/2008US20080176310 Carbonic anhydrase for use diagnostic/prognostic tool in detectingf cell proliferative disorders of breast
07/24/2008US20080176291 Methods and compositions for selectively cleaving DNA containing duplex nucleic acids in a complex nucleic acid mixture, and nuclease compositions for use in practicing the same
07/24/2008US20080176288 Colony stimulating factor fusion protein comprising polyanionic polymer for use tool to enhance drug delivery
07/24/2008US20080176286 Method for making monoclonal antibodies and cross-reactive antibodies obtainanble by the method
07/24/2008US20080176285 N-acetyl glucosamine phosphotransferase for use in treatment and prevention of lysosomal storage diseases
07/24/2008US20080176279 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE)
07/24/2008US20080176268 MN Gene and Protein
07/24/2008US20080176258 Using Carbonic anhydrase expression in breast tissues as diagnostic indicator of cell proliferative disorders
07/24/2008US20080176257 Assay for Antibodies
07/24/2008US20080176252 Amyloid beta-derived diffusible ligands (ADDLs), ADDL-surrogates, ADDL-binding molecules, and uses thereof
07/24/2008US20080176247 Trimeric collagen scaffold antibodies
07/24/2008US20080176231 Apotosis inducing viral protein, in combination with defective p53 protein, for use in treatment of cell proliferative and autoimmune disorders
07/24/2008US20080176214 Using immunoglubulins to measure papilloma viral expression; diagnosisng/prognosing urogenital cell proliferative disorders
07/24/2008US20080175867 genetic engineered proteins useful as immunogens in vaccines; prevention of periodontal disease
07/24/2008US20080175866 involved in the adaptation of microorganisms to its environment, particularly the identification of genes responsible for the virulence of a pathogenic microorganisms
07/24/2008US20080175857 Streptococcus pneumoniae proteins and nucleic acid molecules
07/24/2008US20080175856 Enterococcus Antigens
07/24/2008US20080175855 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines
07/24/2008US20080175854 Point mutations; antibodies; fusion proteins
07/24/2008US20080175853 Virus-like particles for the induction of autoantibodies
07/24/2008US20080175850 Methods for human allografting
07/24/2008US20080175849 Monoclonal antibody for use in diagnosis, prevention and treatment of infectious mononucleosis and cell proliferative disorders
07/24/2008US20080175847 Anti-dll4 antibodies and methods using same
07/24/2008US20080175846 Antibodies against cancer antigen tmeff2 and uses thereof
07/24/2008US20080175844 Activin-like receptor kinase immunoglobulin fusion for prevention and treatment of cell proliferative and vision defects; angiogenesis inhibitors
07/24/2008US20080175842 Compositions and methods for treatment
07/24/2008US20080175841 Antagonistic Anti-hTNFSF13b Human Antibodies
07/24/2008US20080175840 Methods for treating angiogenesis related disorders
07/24/2008US20080175839 Compositions Against Cancer Antigen LIV-1 and Uses Thereof
07/24/2008US20080175838 Using alpha-synuclein specific monoclonal antibody to diagnose, prevent amd treat parkinson's disease
07/24/2008US20080175837 Autophagy regulators; drug screening; dipeptidyl peptidase IV (Dpp4); preservative of organs for transplantation
07/24/2008US20080175835 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases
07/24/2008US20080175819 Vector system
07/24/2008US20080175788 Analyzing for changes in levels of cancer specific genes (CSG) in cells, tissues or bodily fluids compared with levels of CSG in preferably the same cells, tissues, or bodily fluid type of a normal human control: administering antibodies conjugated to cytotoxic agents, which specifically bind CSG
07/24/2008CA2712375A1 A method for commercial isolation of egg yolk igy, its product, and uses of the product
07/24/2008CA2675847A1 Pegylated a.beta. fab
07/24/2008CA2675583A1 Inflammation treatment, detection and monitoring via trem-1
07/24/2008CA2675122A1 Method for detection of human immunodeficiency virus
07/23/2008EP1947460A1 Method of measuring ptx3 with high sensitivity
07/23/2008EP1947184A2 Delta-endotoxin genes and methods for their use
07/23/2008EP1947183A1 Mammalian cell surface antigens; related reagents
07/23/2008EP1947182A1 Fibroblast growth factor-23 molecules and uses thereof
07/23/2008EP1947180A1 Transgenic silkworm capable of producing antibody and method for production thereof
07/23/2008EP1947178A1 Human monoclonal antibody binding to human gm-csf and antigen-binding site thereof
07/23/2008EP1947176A1 Method for stabilization of biological molecule and composition
07/23/2008EP1947174A1 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
07/23/2008EP1947119A2 Treatment of cancer with anti-erb2 antibodies in combination with a chemotherapeutic agent
07/23/2008EP1947112A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
07/23/2008EP1947106A1 Streptococcus pneumoniae methionyl tRNA synthetase
07/23/2008EP1946775A2 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
07/23/2008EP1946774A1 Cerebral infarction-preventive agent
07/23/2008EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection
07/23/2008EP1946768A1 Outer coat protein pa5158 of pseudomonas aeruginosa
07/23/2008EP1945820A2 Toll like receptor 3 modulators, methods and uses
07/23/2008EP1945767A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies
07/23/2008EP1945674A2 Therapeutic anti-her2 antibody fusion polypeptides
07/23/2008EP1945673A2 Targeting and tracing of antigens in living cells
07/23/2008EP1945672A2 Use of ceacam8-specific substances for treating autoimmune diseases and a method for screening substances which induce apoptosis
07/23/2008EP1945671A2 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38
07/23/2008EP1945670A2 Therapeutic agent
07/23/2008EP1945669A1 Chimeric antibodies with new world primate regions
07/23/2008EP1945668A1 Engineered antibodies with new world primate framework regions
07/23/2008EP1945667A1 Composition and method for the treatment of viral infection using camelid heavy chain antibodies
07/23/2008EP1945666A2 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
07/23/2008EP1945665A2 Antibody-based therapeutics with enhanced adcc activity
07/23/2008EP1945664A2 Method and antibodies for detecting nitrofuran
07/23/2008EP1945264A2 Treatment for antiphospholipid-syndrome-related pregnancy complications
07/23/2008EP1945262A2 Fc labeling for immunostaining and immunotargeting
07/23/2008EP1945261A2 Compositions and methods for controlling tissue factor signaling specificity
07/23/2008EP1945260A1 Uses of anti-cd40 antibodies
07/23/2008EP1945259A2 Fusion proteins for blood-brain barrier delivery
07/23/2008EP1945258A2 Tdf-related compounds and analogs thereof
07/23/2008EP1945257A2 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
07/23/2008EP1945256A1 Methods and compositions for modulating wound repair
07/23/2008EP1328287B1 Compositions and methods for wt1 specific immunotherapy
07/23/2008EP1320351B1 Methods of preparing immune globulin and uses thereof
07/23/2008EP1278829B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
07/23/2008EP1270595B1 Anti ccr4 antibody and its fragment
07/23/2008EP1248841B1 Genes differentially expressed in breast cancer
07/23/2008EP1167537B1 Process for producing monoclonal antibody
07/23/2008EP1163271B1 Recombinant il-18 antibodies and their use
07/23/2008EP1123383B1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
07/23/2008EP1082413B1 Aav5 vector and uses thereof
07/23/2008EP1032688B1 Single-chain bifunctional glycoprotein hormones
07/23/2008EP0970206B1 Lage-1 tumor associated nucleic acids
07/23/2008CN101228276A Novel genes and proteins of brachyspira pilosicoli and use of same for diagnosis and therapy
07/23/2008CN101228189A Antigen binding molecules having modified FC regions and altered binding to FC receptors
07/23/2008CN101228188A IL-1β结合抗体及其片段 IL-1β binding antibodies and fragments
07/23/2008CN101228187A Human synthetic single-chain antibodies directed against the common epitope of mutant P53 and their uses
07/23/2008CN101227924A Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
07/23/2008CN101227923A Use of anti-MAdCAM antibodies for the treatment of coeliac disease and tropical sprue
07/23/2008CN101225111A Preparation method of monoclonal antibody and use thereof
07/23/2008CN101224302A Real time individuation poultry egg antibody preparation for anti Hepatitis B or C virus and preparing method and application thereof
07/23/2008CN100404673C Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
07/23/2008CN100404669C Novel reovirus, its antibody and vaccine and use thereof
07/23/2008CN100404554C Antifish lymphocystis virus capsid protein monoclonal antibody, and its preparing method
07/23/2008CN100404553C Sturgeon family fish ovovitellin preparation method and uses
07/23/2008CN100404547C Protein purification by ion exchange chromatography